Sadaf Farooqi

Last updated

Sadaf Farooqi

Sadaf farooqi.jpg
Professor Sadaf Farooqi at the American Diabetes Association's 79th Scientific Session, June 2019
Born
Ismaa Sadaf Farooqi
Alma mater
Known for Genetics of obesity
Scientific career
Fields
Institutions
Thesis Genetics of severe childhood obesity  (2001)
Website www.mrl.ims.cam.ac.uk/research/principal-investigators/i-sadaf-farooqi/

Ismaa Sadaf Farooqi FMedSci FRS is a Wellcome Trust Senior Research fellow [2] in Clinical Science, professor of Metabolism and Medicine at the University of Cambridge and a consultant physician at Addenbrooke's Hospital in Cambridge, UK. [1] [3] [4] [5]

Contents

Education

Farooqi was educated at the University of Birmingham where she studied medicine, and was awarded a Bachelor of Medicine, Bachelor of Surgery degree in 1993. [3] After working as a pre-registration house officer and senior house officer, [3] she moved into research and was awarded a PhD in 2001 from the University of Cambridge for research on the genetics of severe childhood obesity. [6] [7]

Research

Farooqi's research investigates the genetics of obesity. [8] [9] [10] [11] Using candidate genes found in patients with severe obesity, her research group have identified patients with mutations in genes encoding leptin, the leptin receptor and biological targets of leptin action, such as the Melanocortin 4 receptor (MC4R). Her group have also demonstrated that the central leptin-melanocortin axis plays a critical role in the regulation of human food intake. [12] [13] Research in her laboratory has shown that people who carry variants of the MC4R gene have an increased preference for high fat food (such as certain recipes of chicken korma), but a decreased preference for sugary foods like Eton mess. [6] [14] [15]

Her research has also proven that mutations in the KSR2 gene are associated with insulin resistance [16] and that genetic variation in the fat mass and obesity-associated protein (FTO) is associated with diminished hunger. [17] Her research has been funded by the Wellcome Trust, [2] [18] Addenbrooke's Charitable Trust and the Framework Programmes for Research and Technological Development (FP7) from the European Union. [3]

Awards and honours

Farooqi was elected a Fellow of the Royal Society in 2021. [19]

Farooqi was elected a Fellow of the Academy of Medical Sciences (FMedSci) in 2013. [20] Her citation on election reads:

Sadaf Farooqi has fundamentally altered our understanding of human obesity. Her work was key to the discovery of the first mutations that cause human obesity, defining and characterising a range of previously undescribed genetic obesity syndromes, and establishing that the principal driver of obesity in these monogenic syndromes was a failure of the central control of appetite and satiety. She has been greatly committed to the translation of her research into patient benefit and has helped to change clinical attitudes and diagnostic practice world-wide. Obesity is one of the major public health threats facing the international community and Farooqi's research has been critical in bringing real biological insights where these were previously lacking. [20]

Farooqi was interviewed by Jim Al-Khalili on The Life Scientific , first broadcast on BBC Radio 4 in 2017. [6]

Farooqi was awarded the American Diabetes Association's Outstanding Scientific Achievement Award in 2019. [21]

Related Research Articles

<span class="mw-page-title-main">Proopiomelanocortin</span> Mammalian protein found in Homo sapiens

Pro-opiomelanocortin (POMC) is a precursor polypeptide with 241 amino acid residues. POMC is synthesized in corticotrophs of the anterior pituitary from the 267-amino-acid-long polypeptide precursor pre-pro-opiomelanocortin (pre-POMC), by the removal of a 26-amino-acid-long signal peptide sequence during translation. POMC is part of the central melanocortin system.

<span class="mw-page-title-main">Leptin</span> Hormone that inhibits hunger

Leptin is a protein hormone predominantly made by adipose cells and its primary role is likely to regulate long-term energy balance.

<span class="mw-page-title-main">Adipose tissue</span> Loose connective tissue composed mostly by adipocytes

Adipose tissue (also known as body fat, or simply fat) is a loose connective tissue composed mostly of adipocytes. In addition to adipocytes, adipose tissue contains the stromal vascular fraction(SVF) of cells including preadipocytes, fibroblasts, vascular endothelial cells and a variety of immune cells such as adipose tissue macrophages. Adipose tissue is derived from preadipocytes. Its main role is to store energy in the form of lipids, although it also cushions and insulates the body. Far from being hormonally inert, adipose tissue has, in recent years, been recognized as a major endocrine organ, as it produces hormones such as leptin, estrogen, resistin, and cytokines (especially TNFα). In obesity, adipose tissue is also implicated in the chronic release of pro-inflammatory markers known as adipokines, which are responsible for the development of metabolic syndrome, a constellation of diseases, including type 2 diabetes, cardiovascular disease and atherosclerosis. The two types of adipose tissue are white adipose tissue (WAT), which stores energy, and brown adipose tissue (BAT), which generates body heat. The formation of adipose tissue appears to be controlled in part by the adipose gene. Adipose tissue – more specifically brown adipose tissue – was first identified by the Swiss naturalist Conrad Gessner in 1551.

The melanocortins are a family of neuropeptide hormones which are the ligands of the melanocortin receptors The melanocortin system consists of melanocortin receptors, ligands, and accessory proteins. The genes of the melanocortin system are found in chordates. Melanocortins were originally named so because their earliest known function was in melanogenesis. It is now known that the melanocortin system regulates diverse functions throughout the body, including inflammatory response, fibrosis, melanogenesis, steroidogenesis, energy homeostasis, sexual function, and exocrine gland function.

<span class="mw-page-title-main">Agouti-signaling protein</span> Protein-coding gene in the species Homo sapiens

Agouti-signaling protein is a protein that in humans is encoded by the ASIP gene. It is responsible for the distribution of melanin pigment in mammals. Agouti interacts with the melanocortin 1 receptor to determine whether the melanocyte produces phaeomelanin, or eumelanin. This interaction is responsible for making distinct light and dark bands in the hairs of animals such as the agouti, which the gene is named after. In other species such as horses, agouti signalling is responsible for determining which parts of the body will be red or black. Mice with wildtype agouti will be grey, with each hair being partly yellow and partly black. Loss of function mutations in mice and other species cause black fur coloration, while mutations causing expression throughout the whole body in mice cause yellow fur and obesity.

Pseudopseudohypoparathyroidism (PPHP) is an inherited disorder, named for its similarity to pseudohypoparathyroidism in presentation. It is more properly Albright hereditary osteodystrophy although without resistance of parathyroid hormone as frequently seen in that affliction. The term Pseudopseudohypoparathyroidism is used to describe a condition where the individual has the phenotypic appearance of Pseudohypoparathyroidism type 1a, but has normal labs including calcium and PTH.

<span class="mw-page-title-main">FTO gene</span> Protein-coding gene in the species Homo sapiens

Fat mass and obesity-associated protein also known as alpha-ketoglutarate-dependent dioxygenase FTO is an enzyme that in humans is encoded by the FTO gene located on chromosome 16. As one homolog in the AlkB family proteins, it is the first mRNA demethylase that has been identified. Certain alleles of the FTO gene appear to be correlated with obesity in humans.

<span class="mw-page-title-main">Melanocortin 4 receptor</span> Mammalian protein found in Homo sapiens

Melanocortin 4 receptor (MC4R) is a melanocortin receptor that in humans is encoded by the MC4R gene. It encodes the MC4R protein, a G protein-coupled receptor (GPCR) that binds α-melanocyte stimulating hormone (α-MSH). In mouse models, MC4 receptors have been found to be involved in feeding behaviour, the regulation of metabolism, sexual behaviour, and male erectile function.

<span class="mw-page-title-main">Melanocortin 3 receptor</span> Mammalian protein found in Homo sapiens

Melanocortin 3 receptor (MC3R) is a protein that in humans is encoded by the MC3R gene.

<span class="mw-page-title-main">SIM1</span> Genetic protein

Single-minded homolog 1, also known as class E basic helix-loop-helix protein 14 (bHLHe14), is a protein that in humans is encoded by the SIM1 gene.

The central melanocortin system is defined anatomically as a collection of central nervous system circuits which include:

RPGRIP1L is a human gene.

<span class="mw-page-title-main">Tomas Lindahl</span> Swedish-British scientist

Tomas Robert Lindahl FRS FMedSci is a Swedish-British scientist specialising in cancer research. In 2015, he was awarded the Nobel Prize in Chemistry jointly with American chemist Paul L. Modrich and Turkish chemist Aziz Sancar for mechanistic studies of DNA repair.

<span class="mw-page-title-main">Genetics of obesity</span> Relation between obesity and genetic factors

Like many other medical conditions, obesity is the result of an interplay between environmental and genetic factors. Studies have identified variants in several genes that may contribute to weight gain and body fat distribution; although, only in a few cases are genes the primary cause of obesity.

<span class="mw-page-title-main">Stephen O'Rahilly</span> Irish-British physician and scientist

Sir Stephen Patrick O'Rahilly is an Irish-British physician and scientist known for his research into the molecular pathogenesis of human obesity, insulin resistance and related metabolic and endocrine disorders.

<span class="mw-page-title-main">Rudolph Leibel</span>

Rudolph Leibel is the Christopher J. Murphy Professor of Diabetes Research, Professor of Pediatrics and Medicine at Columbia University Medical Center, and Director of the Division of Molecular Genetics in the Department of Pediatrics. He is also co-director of the Naomi Berrie Diabetes Center and executive director of the Russell and Angelica Berrie Program in Cellular Therapy, Co-director of the New York Obesity Research Center and the Columbia University Diabetes and Endocrinology Research Center.

<span class="mw-page-title-main">Setmelanotide</span> Chemical compound

Setmelanotide, sold under the brand name Imcivree, is a medication used for the treatment of genetic obesity caused by a rare single-gene mutation.

<span class="mw-page-title-main">Krishna Chatterjee</span> British endocrinologist (born 1958)

Vengalil Krishna Kumar Chatterjee is a British endocrinologist. He is a professor of endocrinology in the Department of Medicine at the University of Cambridge and a fellow of Churchill College, Cambridge. He is also the director of the Cambridge Clinical Research Centre, part of the National Institute for Health Research (NIHR).

<span class="mw-page-title-main">Pathophysiology of obesity</span>

Pathophysiology of obesity is the study of disordered physiological processes that cause, result from, or are otherwise associated with obesity. A number of possible pathophysiological mechanisms have been identified which may contribute in the development and maintenance of obesity.

<span class="mw-page-title-main">Antonio Vidal-Puig</span> Spanish medical doctor and scientist

Antonio Vidal-Puig is a Spanish medical doctor and scientist who works as a Professor of Molecular Nutrition and Metabolism at the University of Cambridge (UK), best known for advancing the concept that pharmacological targeting of brown fat may serve to treat overweight and obesity in affected individuals, as well as for introducing the concept of adipose tissue "expandability" as an important factor in the pathogenesis of insulin resistance in the context of positive energy balance. His published work focuses on areas such as adipose tissue metabolism and lipotoxicity, regulation of insulin secretion, and the pathophysiology of metabolic syndrome, obesity, and type 2 diabetes.

References

  1. 1 2 Sadaf Farooqi publications indexed by Google Scholar
  2. 1 2 Anon (2016). "Senior Research Fellowships in Clinical Science: people we've funded". wellcome.ac.uk. London: Wellcome Trust. Archived from the original on 25 January 2017.
  3. 1 2 3 4 Sadaf Farooqi's ORCID   0000-0001-7609-3504
  4. Sadaf Farooqi's publications indexed by the Scopus bibliographic database. (subscription required)
  5. Anon (2016). "Professor Sadaf Farooqi: Cambridge Neuroscience". Cambridge: University of Cambridge. Archived from the original on 18 June 2016.
  6. 1 2 3 Al-Khalili, Jim (2017). "Sadaf Farooqi on what makes us fat". London: BBC.
    Is it true that some people put on weight more easily than others? And if so why? It's a question that's close to many of our hearts. And it's a question that medical researcher, Professor Sadaf Farooqi is trying to answer. In 1997, Sadaf noticed that two children she was studying lacked the hormone leptin. From there, she went on to discover the first single gene defect that causes obesity. For most us, how much we eat is within our control. But for children with this rare inherited condition and, it turned out, several other rare genetic disorders, the evidence is clear. A voracious appetite is not a lifestyle choice: it's a biological response to brains signalling starvation. Sadaf tells Jim how she discovered ten rare genetic disorders that cause severe childhood obesity and what this means for the rest of us.
  7. Farooqi, Ismaa Sadaf (2001). Genetics of severe childhood obesity (PhD thesis). University of Cambridge. OCLC   894596925.
  8. Gerken, T.; Girard, C. A.; Tung, Y. -C. L.; Webby, C. J.; Saudek, V.; Hewitson, K. S.; Yeo, G. S. H.; McDonough, M. A.; Cunliffe, S.; McNeill, L. A.; Galvanovskis, J.; Rorsman, P.; Robins, P.; Prieur, X.; Coll, A. P.; Ma, M.; Jovanovic, Z.; Farooqi, I. S.; Sedgwick, B.; Barroso, I.; Lindahl, T.; Ponting, C. P.; Ashcroft, F. M.; O'Rahilly, S.; Schofield, C. J. (2007). "The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase". Science . 318 (5855): 1469–1472. Bibcode:2007Sci...318.1469G. doi:10.1126/science.1151710. PMC   2668859 . PMID   17991826.
  9. OʼRahilly, Stephen; Montague, Carl T.; Farooqi, I. Sadaf; Whitehead, Jonathan P.; Soos, Maria A.; Rau, Harald; Wareham, Nicholas J.; Sewter, Ciaran P.; Digby, Janet E.; Mohammed, Shehla N.; Hurst, Jane A.; Cheetham, Christopher H.; Earley, Alison R.; Barnett, Anthony H.; Prins, Johannes B. (1997). "Congenital leptin deficiency is associated with severe early-onset obesity in humans". Nature . 387 (6636): 903–908. Bibcode:1997Natur.387..903M. doi: 10.1038/43185 . PMID   9202122. S2CID   205032762.
  10. Speliotes, Elizabeth K; Willer, Cristen J; Berndt, Sonja I; Monda, Keri L; Thorleifsson, Gudmar; Jackson, Anne U; Allen, Hana Lango; Lindgren, Cecilia M; Luan, Jian'an; Mägi (2010). "Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index". Nature Genetics . 42 (11): 937–948. doi:10.1038/ng.686. PMC   3014648 . PMID   20935630.
  11. Farooqi, I. Sadaf; Jebb, Susan A.; Langmack, Gill; Lawrence, Elizabeth; Cheetham, Christopher H.; Prentice, Andrew M.; Hughes, Ieuan A.; McCamish, Mark A.; O'Rahilly, Stephen (1999). "Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency". New England Journal of Medicine . 341 (12): 879–884. doi:10.1056/NEJM199909163411204. PMID   10486419.
  12. Farooqi, I. Sadaf; O'Rahilly, Stephen (2006). "Genetics of Obesity in Humans". Endocrine Reviews . 27 (7): 710–718. doi: 10.1210/er.2006-0040 . PMID   17122358.
  13. Gallager, James (2013). "Slow metabolism 'obesity excuse' true". London: BBC. Archived from the original on 6 February 2016.
  14. Brierley, Craig (2016). "Chicken korma, Eton mess and a genetic variant provide clues to our food choices". Cambridge: University of Cambridge. Archived from the original on 8 November 2016.
  15. van der Klaauw, Agatha A.; Keogh, Julia M.; Henning, Elana; Stephenson, Cheryl; Kelway, Sarah; Trowse, Victoria M.; Subramanian, Naresh; O'Rahilly, Stephen; Fletcher, Paul C.; Farooqi, I. Sadaf (2016). "Divergent effects of central melanocortin signalling on fat and sucrose preference in humans". Nature Communications . 7: 13055. Bibcode:2016NatCo...713055V. doi:10.1038/ncomms13055. PMC   5059464 . PMID   27701398. Open Access logo PLoS transparent.svg
  16. Pearce, Laura R.; Atanassova, Neli; Banton, Matthew C.; Bottomley, Bill; van der Klaauw, Agatha A.; Revelli, Jean-Pierre; Hendricks, Audrey; Keogh, Julia M.; Henning, Elana; Doree, Deon; Jeter-Jones, Sabrina; Garg, Sumedha; Bochukova, Elena G.; Bounds, Rebecca; Ashford, Sofie; Gayton, Emma; Hindmarsh, Peter C.; Shield, Julian P.H.; Crowne, Elizabeth; Barford, David; Wareham, Nick J.; O'Rahilly, Stephen; Murphy, Michael P.; Powell, David R.; Barroso, Ines; Farooqi, I. Sadaf (2013). "KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation". Cell . 155 (4): 765–777. doi:10.1016/j.cell.2013.09.058. PMC   3898740 . PMID   24209692.
  17. Wardle, Jane; Carnell, Susan; Haworth, Claire M. A.; Farooqi, I. Sadaf; O'Rahilly, Stephen; Plomin, Robert (2008). "Obesity Associated Genetic Variation in FTO is Associated with Diminished Satiety". The Journal of Clinical Endocrinology and Metabolism . 93 (9): 3640–3643. doi: 10.1210/jc.2008-0472 . PMID   18583465. S2CID   13929741.
  18. Sadaf Farooqi discusses how our genes affect our weight on YouTube Wellcome Collection
  19. "Royal Society elects outstanding new Fellows and Foreign Members". The Royal Society. 6 May 2021. Retrieved 21 May 2021.
  20. 1 2 Anon (2013). "Professor Sadaf Farooqi FMedSci". acmedsci.ac.uk. London: Academy of Medical Sciences. Archived from the original on 1 August 2016.
  21. "2019 Outstanding Scientific Achievement Award - Sadaf Farooqi, MB, ChB (Hons), PhD". professional.diabetes.org. Retrieved 14 November 2019.